Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sivelestat sodium tetrahydrate (ONO5046 sodium tetrahydrate) is a competitive inhibitor of human neutrophil elastase, with an IC50 of 44 nM and a Ki of 200 nM. Sivelestat (EI546) sodium tetrahydrate has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 42.00 | |
10 mg | In stock | $ 67.00 | |
25 mg | In stock | $ 129.00 | |
50 mg | In stock | $ 237.00 | |
100 mg | In stock | $ 347.00 | |
200 mg | In stock | $ 516.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 74.00 |
Description | Sivelestat sodium tetrahydrate (ONO5046 sodium tetrahydrate) is a competitive inhibitor of human neutrophil elastase, with an IC50 of 44 nM and a Ki of 200 nM. Sivelestat (EI546) sodium tetrahydrate has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. |
In vitro | Sivelestat (ONO-5046) is not an inhibitor of trypsin, thrombin, plasmin, plasma kallikrein, pancreas kallikrein, chymotrypsin, or cathepsin G, even at concentrations up to 100 μM[1]. However, it effectively inhibits neutrophil elastase across various species, demonstrating IC50 values of 44 nM (human), 36 nM (rabbit), 19 nM (rat), 37 nM (hamster), and 49 nM (mouse), showcasing its specificity and potential for therapeutic applications[1]. |
In vivo | Sivelestat (ONO-5046, 0.021-2.1 mg/kg, intratracheally) suppresses lung hemorrhage in hamster (ID50 = 82 pg/kg) by intratracheal administration and increase of skin capillary permeability in guinea pig (ID50 = 9.6 mg/kg) by intravenous administration, both of which are induced by human neutrophil elastase[1]. Sivelestat (10 mg/kg, infusion via the tail vein) ameliorates lung injury after hemorrhagic shock in rats[2]. Sivelestat (15, 60 mg/kg, ip) prevents ischemia–reperfusion injury in the rat bladder[3]. |
Synonyms | ONO-5046 sodium tetrahydrate, Elaspol, ONO 5046, ONO5046 sodium tetrahydrate, Elaspol sodium tetrahydrate, ONO-5046, Sivelestat Sodium, Sivelestat Sodium Hydrate, ONO5046 |
Molecular Weight | 528.51 |
Formula | C20H29N2NaO11S |
CAS No. | 201677-61-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225 mg/mL (425.7 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sivelestat sodium tetrahydrate 201677-61-4 Proteases/Proteasome Serine Protease ONO-5046 sodium tetrahydrate Elaspol ONO-5046 sodium Tetrahydrate ONO 5046 ONO5046 sodium tetrahydrate Elaspol sodium tetrahydrate Elaspol sodium ONO-5046 ONO5046 sodium Sivelestat Sodium Sivelestat sodium ONO5046 sodium Tetrahydrate ONO-5046 sodium Elaspol sodium Tetrahydrate Sivelestat sodium Tetrahydrate Sivelestat Sodium Hydrate ONO5046 inhibitor inhibit